- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Cortex Pharmaceuticals
Total 20161 results
-
Vertex Pharmaceuticals IncorporatedTerminatedHepatitis CUnited States, Canada, Germany, Puerto Rico, Spain
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis C VirusUnited States, United Kingdom, Canada, Germany, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis CUnited States, Canada, Netherlands, Puerto Rico, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedPartial EpilepsyUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis CUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis | Hepatitis CUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedRheumatoid ArthritisPoland, Croatia, Russian Federation, Bulgaria, Czech Republic, Former Serbia and Montenegro, Slovakia, Slovenia, Ukraine
-
Vertex Pharmaceuticals IncorporatedCompletedRheumatoid ArthritisBulgaria, Croatia, Former Serbia and Montenegro, Poland, Russian Federation, Slovenia
-
Vertex Pharmaceuticals IncorporatedRecruitingAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedRecruitingProteinuric Kidney DiseaseUnited States, Spain, Ghana, France, United Kingdom, Belgium, Brazil, Colombia, Portugal, Canada, Puerto Rico, Netherlands
-
Vertex Pharmaceuticals IncorporatedRecruitingDiabetes Mellitus, Type 1 | Impaired Hypoglycemic Awareness | Severe HypoglycemiaUnited States, Norway, Italy, Canada, France, United Kingdom, Switzerland, Netherlands, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, United Kingdom, Canada, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedAcute PainUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, United Kingdom, New Zealand, Israel, Australia, Ireland, Germany, Sweden, Czechia, Portugal, Hungary
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, Spain, Australia, Canada
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Canada, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisCanada, France, Germany, United Kingdom, Israel, Australia, Spain, Netherlands, Denmark, Switzerland
-
Vertex Pharmaceuticals IncorporatedCompletedAlpha1-Antitrypsin DeficiencyUnited States, Germany, Canada, Ireland, Sweden, United Kingdom
-
Vertex Pharmaceuticals IncorporatedTerminatedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Canada, Denmark, Poland, Switzerland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Belgium, Netherlands
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Belgium, Netherlands, United Kingdom, Australia, France, Canada, Denmark, Germany, Italy, Israel
-
Vertex Pharmaceuticals IncorporatedCompletedA Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following BunionectomyAcute PainUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedEpilepsyUnited States, Germany
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, United Kingdom, Canada, Germany, Australia, France, Italy, Czechia, Austria, Greece, Sweden
-
Vertex Pharmaceuticals IncorporatedTerminatedCervical Spinal Cord InjuryUnited States, Canada
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, United Kingdom, Germany, Belgium, Austria, Ireland, Italy, France
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, Germany, Switzerland, Israel, Netherlands, Belgium, Italy, United Kingdom, France
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, France, Spain, Israel, Australia, Austria
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, Germany, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Belgium, Australia, Denmark, Canada, Sweden